Cytogen Inc Ordinary Shares 217330

Morningstar Rating
₩2,245.00 −35.00 (1.54%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

217330 is trading within a range we consider fairly valued.
Price
₩2,280.00
Fair Value
LOCK|MY.L?l?BxDX
Uncertainty
LOCK|dm ?@ZyH
1-Star Price
LOCK|?G.^gf@$^#
5-Star Price
LOCK|f<.b@!!?$
Economic Moat
LOCK|y@
Capital Allocation
—

Trading Information

Previous Close Price
₩2,280.00
Day Range
₩2,155.00–2,340.00
52-Week Range
₩2,100.00–11,200.00
Bid/Ask
₩2,245.00 / ₩2,255.00
Shares Outstanding
23.13M
Market Cap
₩51.92B
Volume/Avg
27,487 / 52,881

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.92
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms. Its services and products include: cancer drug development and monitoring, companion diagnostics, clinical research, CLIA-certified services, preclinical xenograft models, and liquid biopsy equipment.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
45

Valuation

Metric
217330
Price/Earnings (Normalized)
—
Price/Book Value
2.17
Price/Sales
1.92
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
217330
Quick Ratio
6.30
Current Ratio
7.21
Interest Coverage
−4.94
Quick Ratio
217330

Profitability

Metric
217330
Return on Assets (Normalized)
−13.57%
Return on Equity (Normalized)
−28.45%
Return on Invested Capital (Normalized)
−12.76%
Return on Assets
217330

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|BSfJ&$JLOCK|^T$255B
Danaher Corp
DHR
LOCK|tf&!<JGLOCK|F%$160B
IDEXX Laboratories Inc
IDXX
LOCK|Wt#K!LBLOCK|nK$54B
Agilent Technologies Inc
A
LOCK|?L&$B%qLOCK|@rq$49B
Waters Corp
WAT
LOCK|<<lv?#LOCK|&Xk$45B
IQVIA Holdings Inc
IQV
LOCK|%&bmG>LOCK|TvSrD$41B
Mettler-Toledo International Inc
MTD
LOCK|b@bnz>RLOCK|Gl<R$34B
Illumina Inc
ILMN
LOCK|Ff<H&^WLOCK|g&lJl$30B
Labcorp Holdings Inc
LH
LOCK|#@&^!f^jLOCK|KT&X$30B
Quest Diagnostics Inc
DGX
LOCK|#@bJf&LOCK|b#Pf$29B

Sponsor Center